- Home
- SPRU vs ALGS Comparison
SPRU vs ALGS Comparison
Compare SPRU & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- ALGS
- Stock Information
- Founded
- SPRU 2008
- ALGS 2018
- Country
- SPRU United States
- ALGS United States
- Employees
- SPRU N/A
- ALGS N/A
- Industry
- SPRU Auto Parts:O.E.M.
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- SPRU Consumer Discretionary
- ALGS Health Care
- Exchange
- SPRU Nasdaq
- ALGS Nasdaq
- Market Cap
- SPRU 34.9M
- ALGS 36.0M
- IPO Year
- SPRU N/A
- ALGS 2020
- Fundamental
- Price
- SPRU $1.99
- ALGS $7.98
- Analyst Decision
- SPRU
- ALGS Strong Buy
- Analyst Count
- SPRU 0
- ALGS 1
- Target Price
- SPRU N/A
- ALGS $70.00
- AVG Volume (30 Days)
- SPRU 46.5K
- ALGS 134.3K
- Earning Date
- SPRU 08-13-2025
- ALGS 08-05-2025
- Dividend Yield
- SPRU N/A
- ALGS N/A
- EPS Growth
- SPRU N/A
- ALGS N/A
- EPS
- SPRU N/A
- ALGS N/A
- Revenue
- SPRU $87,638,000.00
- ALGS $3,270,000.00
- Revenue This Year
- SPRU $2.12
- ALGS N/A
- Revenue Next Year
- SPRU N/A
- ALGS $51.55
- P/E Ratio
- SPRU N/A
- ALGS N/A
- Revenue Growth
- SPRU 9.48
- ALGS N/A
- 52 Week Low
- SPRU $1.42
- ALGS $3.76
- 52 Week High
- SPRU $3.68
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- SPRU 55.21
- ALGS 64.99
- Support Level
- SPRU $1.82
- ALGS $7.43
- Resistance Level
- SPRU $1.99
- ALGS $8.36
- Average True Range (ATR)
- SPRU 0.11
- ALGS 0.73
- MACD
- SPRU 0.01
- ALGS 0.20
- Stochastic Oscillator
- SPRU 54.55
- ALGS 94.08
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is an owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's customers are homeowners and the Company's core solar service offerings generate revenues through, the sale of electricity generated by its home solar energy systems to homeowners, third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and the servicing of those agreements for other institutional owners of home solar energy systems.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.